ABOS
Price
$1.79
Change
+$0.02 (+1.13%)
Updated
Dec 24 closing price
96 days until earnings call
CMPX
Price
$1.50
Change
-$0.01 (-0.66%)
Updated
Dec 24 closing price
84 days until earnings call
Ad is loading...

ABOS vs CMPX

Header iconABOS vs CMPX Comparison
Open Charts ABOS vs CMPXBanner chart's image
Acumen Pharmaceuticals
Price$1.79
Change+$0.02 (+1.13%)
Volume$363.19K
CapitalizationN/A
Compass Therapeutics
Price$1.50
Change-$0.01 (-0.66%)
Volume$134.47K
CapitalizationN/A
ABOS vs CMPX Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. CMPX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and CMPX is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (ABOS: $1.79 vs. CMPX: $1.50)
Brand notoriety: ABOS and CMPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 132% vs. CMPX: 29%
Market capitalization -- ABOS: $107.54M vs. CMPX: $206.38M
ABOS [@Biotechnology] is valued at $107.54M. CMPX’s [@Biotechnology] market capitalization is $206.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileCMPX’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • CMPX’s FA Score: 0 green, 5 red.
According to our system of comparison, CMPX is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while CMPX’s TA Score has 3 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 4 bearish.
  • CMPX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than CMPX.

Price Growth

ABOS (@Biotechnology) experienced а -8.67% price change this week, while CMPX (@Biotechnology) price change was -1.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

ABOS is expected to report earnings on Mar 31, 2025.

CMPX is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMPX($206M) has a higher market cap than ABOS($108M). CMPX YTD gains are higher at: -3.846 vs. ABOS (-53.385). CMPX has higher annual earnings (EBITDA): -53.58M vs. ABOS (-77.89M). ABOS has more cash in the bank: 200M vs. CMPX (135M). CMPX has less debt than ABOS: CMPX (6.88M) vs ABOS (28.5M). CMPX has higher revenues than ABOS: CMPX (850K) vs ABOS (0).
ABOSCMPXABOS / CMPX
Capitalization108M206M52%
EBITDA-77.89M-53.58M145%
Gain YTD-53.385-3.8461,388%
P/E RatioN/AN/A-
Revenue0850K-
Total Cash200M135M148%
Total Debt28.5M6.88M414%
TECHNICAL ANALYSIS
Technical Analysis
ABOSCMPX
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 6 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Ad is loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FMCC2.620.01
+0.42%
Freddie Mac
VEXTF0.13N/A
N/A
Vext Science Inc.
RYCEY7.32-0.01
-0.14%
Rolls Royce Holdings plc
OLYMY15.04-0.04
-0.27%
Olympus Corp.
MONOY16.98-0.39
-2.25%
Monotaro Co., Ltd.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with INZY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+1.13%
INZY - ABOS
50%
Loosely correlated
-2.66%
MGTX - ABOS
49%
Loosely correlated
+1.31%
BEAM - ABOS
48%
Loosely correlated
+0.38%
AURA - ABOS
48%
Loosely correlated
+0.61%
SNDX - ABOS
47%
Loosely correlated
-1.80%
More

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with TRDA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
-0.66%
TRDA - CMPX
44%
Loosely correlated
+0.57%
ABOS - CMPX
41%
Loosely correlated
+1.13%
ABCL - CMPX
40%
Loosely correlated
+1.03%
IPSC - CMPX
40%
Loosely correlated
+0.49%
FHTX - CMPX
40%
Loosely correlated
+1.83%
More